“dna” Archives

Entry Author Date Location
CRISPR Therapeutics Raises $56M In IPO, Half Its Rivals’ Haul 10/18/16 Boston
With Bugs As Drugs, Evelo CEO Plans Immune, Cancer Trials in 2017 07/12/16 Boston
Seattle Week in Review: A Tragic Summer, Hoping “This Too Shall Pass” 07/08/16 Seattle
Ginkgo Gulps $100M to Build Synthetic Food, Fragrance Business 06/08/16 Boston
Syros Files For IPO to Push “Gene Control” Drugs Through First Trials 06/06/16 Boston
With $43.5M Startup Cash, Homology Med Chases New Gene Editing Twist 05/02/16 Boston
How a San Antonio Company Joined In to Help Conjoined Twins In Need 04/15/16 Texas
Tour of Texas: Cancer Moonshot, Lumos, Robyn Metcalfe, & Esperance 04/07/16 Texas
Old Dog, New Tests: Embark Uses DNA Kit to Promote Canine Health 04/04/16 Texas
Stealthy MIT Spinout Ribon, Led by a Sanofi Vet, Takes Aim at Cancer 03/03/16 Boston
Pronutria, Eyeing Clinical Push, Gets $42.5M From Nestle Health 02/23/16 Boston
Ex-Biogen Exec’s New Startup Gets $61M More For Exosome Drugs 01/26/16 Boston
Same Twist, New Funding: Gene Synthesizer Raises $61M Series D 01/19/16 San Francisco
With $100M, Guardant Health to Expand Reach of Blood Test for Cancer 01/07/16 San Francisco
Synthetic Biology Primer: In Conversation With Richard Kitney, Part 1 12/31/15 National
In the Face of Genomic Data Challenges, the Cloud Keeps Us Afloat 12/29/15 San Diego
With Drugs in Clinic, Constellation Nabs $55M For IPO Push 12/09/15 Boston
Big Bucks, Tiny Bubbles: Ex-Biogen Exec’s Exosome Startup Nabs $80M 11/17/15 Boston
Synthorx Makes Proteins Using Expanded Alphabet of Synthetic DNA 08/20/15 San Diego
Exact Sciences Outlines Pipeline of Diagnostics for Deadliest Cancers 06/30/15 Wisconsin
Sharpening Its Focus On Drugs, Pronutria Bags $39M From Fidelity, Flagship 05/28/15 Boston
The Innovation Challenge: Assessing BioPharma Startups 05/04/15 Seattle
A New Day for Digital DNA 04/14/15 Boston
Six Takeaways From “New York’s Life Science Disruptors” 03/16/15 New York
Resistance Is Futile: Why That’s A Good Thing In Biomedicine 02/09/15 Seattle
Exosome Dx, Aiming to Commercialize “Liquid Biopsies,” Seeks $25M 01/28/15 Boston
Biotech Startups Tap Spider Genes in Quest to Spin Silk Gold 10/14/14 Raleigh Durham
With FDA Nod, T2 Bio’s Sepsis Test Heads to Commercial Proving Ground 09/23/14 Boston
Hear Epizyme, Sage, Zafgen Share Their Stories on Oct. 8 09/11/14 Boston
Military Strategies Being Used in the War on Cancer 08/04/14 Seattle
Page 1 of 3 next page »